24/7 Customer Support

Dermatology Drugs Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2031

Global Dermatology Drugs Market: By Drug Type (Branded Prescription Drugs, Generic Prescription Drugs, Over-The Counter Drugs (OTC)); By Formulation (Ointments, Cream, Lotion, Gel, Tablets, Other Formulations); By Rout of Administration (Oral Medicines, Topical Medicines, Parenteral Medicines); By Therapeutic Application (Acne, Dermatitis, Psoriasis, Rosacea, Inflammatory dermatoses, Others); By Distribution Channel (Retail Channel, Non-retail, Online Channel); By Country/Region—Industry Dynamics, Market Size and Opportunity Forecast till 2031

  • Published Date: Dec-2022  |   Format: pdfpowerpointexcel  |  Report ID: AA1222333  | Delivery: 2 to 4 Hours


Report AttributeDetails
Market Size Value in 2022US$ 18.42 Billion
Expected Revenue in 2031US$ 45.35 Billion
Historic Data2018-2021
Base Year2022
Forecast Period2023-2031
UnitValue (USD Bn)
Segments coveredBy Drug Type, By Formulation, By Route of Administration, By Therapeutic Application, By Distribution Channel, By Region
Key Companies                                                                        Amgen Inc, Bausch Health Companies Inc., Botanix Pharmaceuticals, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, LEO Pharma A/S, Merck KGaA, Mylan N.V., Novartis AG, Pfizer Inc., Other Prominent Players
Customization ScopeGet your customized report as per your preference. Ask for customization


The market size of the global dermatology drugs was valued at US$ 18.42 Bn in 2022.

The market is registered to grow at a CAGR of 11.0% during 2023-2030.

Rising demand for skin- and hair-related formulations among people and rise in skin related diseases among people are the factors triggering growth of the dermatology drugs market. 

Rising prices of dermatology drugs and shortage of workforce/physicians and dermatologists are the factors restraining market growth.

Surge in new drug approvals is current trend in the market. 

The various segmentations considered to analyze the global dermatology drugs are based on drug type, formulation, route of administration, therapeutic application, distribution channel, and country.

Negative impact of climate change on skin will shift people towards dermatology drugs as a remedy for skin issues

Branded Prescription Drugs segment dominated the global dermatology drugs in 2022.

Offline distribution channel held the highest segmental share in 2022.

North America dominated the global dermatology drugs market in 2022.

Novartis AG, Pfizer Inc., Johnson & Johnson, and Amgen Inc are the key players analyzed in the global dermatology drugs market.

The pandemic had a negative impact on the global dermatology drugs market, with a 4.0% drop in Y-O-Y growth of 2019-2020.